12 Health Care Stocks Moving In Thursday's Intraday Session

Loading...
Loading...

 

Gainers

  • Longeveron LGVN stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million shares, making up 8203.2% of its average full-day volume over the last 100 days. The company's market cap stands at $225.6 million.
  • Clovis Oncology CLVS stock increased by 53.03% to $2.52. The current volume of 164.6 million shares is 3327.9% of Clovis Oncology's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $359.1 million.
  • SAB Biotherapeutics SABS stock rose 37.3% to $3.57. Trading volume for SAB Biotherapeutics's stock is 1.5 million as of 13:31 EST. This is 1521.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $153.3 million. As per the press release, Q4 earnings came out 2 days ago.
  • Icosavax ICVX stock moved upwards by 28.51% to $6.85. Trading volume for Icosavax's stock is 3.2 million as of 13:31 EST. This is 1254.0% of its average full-day volume over the last 100 days. The company's market cap stands at $267.4 million. The company's, Q4 earnings came out yesterday.
  • Trevena TRVN shares increased by 22.43% to $0.54. As of 13:31 EST, this security is trading at a volume of 8.8 million shares, making up 1148.3% of its average full-day volume over the last 100 days. The company's market cap stands at $88.8 million. As per the news, the Q4 earnings report came out today.
  • Creative Medical Tech CELZ stock increased by 18.28% to $4.01. As of 13:31 EST, Creative Medical Tech's stock is trading at a volume of 17.6 million, which is 321.2% of its average full-day volume over the last 100 days. The company's market cap stands at $25.3 million. As per the news, the Q4 earnings report came out yesterday.

 

Losers

  • Acutus Medical AFIB stock declined by 24.4% to $1.46 during Thursday's regular session. Trading volume for Acutus Medical's stock is 520.3K as of 13:31 EST. This is 103.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.8 million. As per the press release, Q4 earnings came out yesterday.
  • Hillstream BioPharma HILS stock fell 23.65% to $1.55. Trading volume for this security as of 13:31 EST is 910.7K, which is 126.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.4 million.
  • Sharecare SHCR shares declined by 18.34% to $2.69. As of 13:31 EST, this security is trading at a volume of 2.4 million shares, making up 167.5% of its average full-day volume over the last 100 days. The company's market cap stands at $913.6 million. As per the news, the Q4 earnings report came out today.
  • NRX Pharmaceuticals NRXP stock declined by 17.02% to $2.37. The current volume of 1.6 million shares is 189.2% of NRX Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The company's market cap stands at $157.5 million. The company's, Q4 earnings came out today.
  • Vyant Bio VYNT shares declined by 16.46% to $1.34. Trading volume for Vyant Bio's stock is 1.2 million as of 13:31 EST. This is 274.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $38.9 million. As per the press release, Q4 earnings came out yesterday.
  • OncoSec Medical ONCS stock decreased by 15.95% to $1.16. OncoSec Medical's stock is trading at a volume of 390.6K shares as of 13:31 EST. This is 302.1% of its average full-day volume over the last 100 days. The company's market cap stands at $45.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Intraday UpdateMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...